Bill > S01703

This bill authorizes pharmacists to administer United States Food and Drug Administration (FDA) approved reversible progestin-only contraceptive injections under specific conditions. Pharmacists can provide these injections based on a non-patient specific order from a licensed physician or certified nurse practitioner. Before administering the injection, pharmacists must first have the patient complete a self-screening risk assessment questionnaire to identify potential risk factors and provide a fact sheet explaining clinical considerations, usage instructions, and follow-up healthcare information. Pharmacists are required to receive special training to perform these injections and must notify the patient's primary healthcare provider within 72 hours of administration, unless the patient opts out. The bill also allows pharmacists to decline administering the injection if they believe potential adverse effects or complications could endanger the patient's health. Patients have the ability to opt out of practitioner reporting requirements. The law will take effect one year after becoming law, giving time for necessary regulations and training to be established. This bill aims to increase access to contraceptive healthcare by expanding the role of pharmacists in providing reproductive health services.

Education

https://www.nysenate.gov/legislation/bills/2025/S1703